Showing results (1-10 of 148) with videos related to
Sort By:
Pageof 15
Drugs|December 5, 2024
Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment SituationsEhab Atallah, Michael DeiningerCurrent Treatment Options in Oncology|June 10, 2023
Proposals for Clinical Trials in Chronic Myelomonocytic LeukemiaAlexandra Rezazadeh, Michael Deininger, Ehab AtallahClinical Lymphoma, Myeloma & Leukemia|June 8, 2019
Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Tyrosine Kinase Inhibitor Therapy CessationVamsi Kota, Ehab AtallahCurrent Opinion in Hematology|January 27, 2007
Optimal initial therapy for patients with newly diagnosed chronic myeloid leukemia in chronic phaseEhab Atallah, Jorge CortesExpert Review of Anticancer Therapy|May 19, 2009
Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasmsEhab Atallah, Srdan VerstovsekSeminars in Hematology|July 23, 2009
Practical considerations for the management of patients in the tyrosine kinase inhibitor eraMichael O'Dwyer, Ehab AtallahExpert Opinion on Emerging Drugs|November 29, 2012
Emerging drugs for myelofibrosisEhab Atallah, Srdan VerstovsekExpert Opinion on Investigational Drugs|April 10, 2021
Do histone deacytelase inhibitors and azacitidine combination hold potential as an effective treatment for high/very-high risk myelodysplastic syndromes?Talha Badar, Ehab AtallahClinical Lymphoma, Myeloma & Leukemia|March 18, 2023
SOHO State of the Art Updates and Next Questions | Update on Treatment-Free Remission in Chronic Myeloid Leukemia (CML)Sherrie Mikhaeel, Ehab AtallahCurrent Hematologic Malignancy Reports|October 7, 2021
Treatment-Free Remission: the New Goal in CML TherapyEhab Atallah, Kendra SweetPageof 15